Ning Xu, PhD

Ph.D., Molecular Medicine and Genetics from Medical College of Georgia
Dr. Xu is a Senior Scientist at IMBCR. Prior to joining IMBCR, she received her Medical degree from Tongji Medical College, Huazhong University of Science and Technology, China in 2001, and pursued her Ph.D. in Molecular Medicine and Genetics from Medical College of Georgia between 2002 and 2007. Dr. Xu completed her postdoctoral training at Cedars-Sinai Medical Center in 2012. Her work focused on epigenetic mechanisms underlying the development of polycystic ovary syndrome. After she finished her postdoctoral training, Dr. Xu continued the epigenetic project as a Project Scientist. She created androgenized zebrafish by exposing their embryos to testosterone. She found early embryonic androgen exposure-induced changes in global methylation status and glucose homeostasis in two generations of fish. Dr. Xu joined a biotechnology company in 2015; she was in charge of overall progress on assay validations, design assays, and final science and technical reports for small business grants. Dr. Xu became a member of the IMBCR staff in 2018. Her project focuses on the role of immune regulatory proteins in multiple myeloma, and the potential effects of specific drugs on the function of these proteins.